TrialClinical & developmental immunology2011

Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.

Sarah M Bray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.